A Post-Authorisation Safety Study (PASS) to Assess the Effectiveness of the Risk Minimisation Measures of Domperidone – Physician Survey

11/11/2016
02/04/2024
EU PAS number:
EUPAS16095
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

PASS Study_DUS_Physician Survey_Domperidone_JNJ-17296812-AAA_0005_EDMS-ERI-90221144_8.0

English (355.1 KB - PDF) View document
Study results
Study results

Domperidone PASS Study RRA-17004_CSR_Final 27JUN2017

English (606.64 KB - PDF) View document
Study report
Other information